Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam added to bupivacaine versus bupivacaine alone for combined sciatic and saphenous nerve block in foot and ankle surgery
PACTR202203606484149Phase 1Recruiting
- Sponsor
- Mansoura University
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of midazolam and bupivacaine in perioperative pain (2 arms), sponsored by Mansoura University. Primary endpoints: Onset of successful sensory block, Duration of sensory block and 2 more. Started Feb 2022; status: recruiting.
02
Drugs
midazolambupivacaine
03
Conditions
perioperative pain
Beyond the preview
Go deeper on PACTR202203606484149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202203606484149.